Device Week, 4 February 2021 – SPACs In Medtech; Manus’ Parkinson’s Pen; TAVR During COVID
Executive Summary
This week’s podcast includes an update on the growing trend of “blank check” companies taking medtech companies public, a spotlight on Manus’ pen that can diagnose Parkinson’s disease, and a look at how the pandemic is impacting valve replacements.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics in this episode:
-
Blank Check Companies’ Hunt For Innovative Medtech Start-Ups To Heat Up Further, Experts Predict
-
Start-Up Spotlight: Manus Neurodynamica Hopes To Write The End Of Traditional Parkinson’s Diagnosis